ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Thiogenesis Therapeutics Corp

Thiogenesis Therapeutics Corp (TTI)

0.57
0.00
( 0.00% )
Updated: 09:54:19

Thiogenesis Therapeutics Corp Financial Summary

The current TTI market cap is 25.4M. The company's latest EPS is CAD -0.1129 and P/E is -1.95.

Year End December 30 2023 20212021202220222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Revenue 00000
Operating Income 0-1.39M-3k-3.61M-4.72M
Net Income -93k-1.22M-224k-3.92M-5.03M
Year End December 30 2023 20212021202220222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Assets 146k231k3.43M6.29M7.24M
Total Liabilities 63k1.29M3.49M307k1.71M
Total Equity 83k-1.06M-61k5.98M5.53M

Cash Flow

Year End December 30 2023 20212021202220222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Operating -36k-768k-67k-2.09M-3.25M
Investing N/A N/A N/A 107k N/A
Financing N/A 819k3.33M8.13M4.12M
Market Cap 25.4M
Price to Earnings Ratio -1.95
Price to Sales Ratio 0
Price to Cash Ratio 1.39
Price to Book Ratio 1.77
Dividend Yield -

Share Statistics

Shares Outstanding 44.57M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0.01 (1.75%)

Company Info

Company Name Thiogenesis Therapeutics Corp
Address 4 king street west, ste. 401
toronto, ontario M5H 1B6
Website https://www.thiogenesis.com
Industry unit inv tr, closed-end mgmt (6726)